06-75A50126R00001_RFP Att 5 BARDA Dose Tracker Template.xlsx

XLSX spreadsheet 115 KB Posted Aug 17, 2026

Attached to: Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation number: 75A50126R00001_RFP_NPIVS_27
Issued by: Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response

About this file

Written by GovTribe AI · Aug 17, 2026

This is a Dose Tracker Template designed by the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response (ASPR), and Biomedical Advanced Research and Development Authority (BARDA) for contractors to report manufacturing and inventory data for vaccines, therapeutics, and hyperimmune globulins. The template, Version 3.2 dated August 20, 2025, serves as a standardized Excel workbook for capturing real-time production metrics across multiple manufacturing stages, with data classified as FOUO, Proprietary, and Company Confidential.

The template comprises multiple interconnected tabs organized by color-coding to indicate update frequency and purpose. Green informational tabs include the introduction and dictionary; blue occasional-update tabs cover Master Data, SKU Lookup, and Dose Projections; orange daily-update tabs track Bulk Drug Substance, Filled Drug Product, Final Released Product, Inventory, Reallocation, and Shipped data; and black reference tabs provide validation values. Contractors must complete Master Data with organization, location, and facility capability details; SKU Lookup with product component information including unit measures, dose targets, and FDA approval status; and operational tabs recording lot numbers, quantities produced, manufacturing dates, potency assay results, expiration dates, and internal lot release dates. The template calculates projected doses using bulk potency assumptions, loss factors, and variance data. The Inventory tab captures point-in-time stock levels by lot and location, while the Reallocation tab accounts for product diverted to clinical trials, stability studies, or destroyed due to damage or expiration. The Shipped tab documents actual distribution with bill of lading information, carrier details, and consignee information. Data submission timing and refresh rates will be provided by the Contracting Officer's Representative (COR), with all submissions combining contractor data for centralized BARDA reporting to leadership.

View the file

Other files

File	Type	Posted
01-75A50126R00001_RFP_Final.pdf	PDF	Sep 11, 2026
21_75A50126R00001_RFP_0001_RFP File 2 of 3.pdf	PDF	Sep 11, 2026
22_75A50126R00001_RFP_0001 Att. 20 BARDA Responses to Contractor Question No's 1-7.pdf	PDF	Sep 11, 2026
21_75A50126R00001_RFP_0001_RFP File 3 of 3.pdf	PDF	Sep 11, 2026
21_75A50126R00001_RFP_0001_RFP File 1 of 3.pdf	PDF	Sep 11, 2026
20_75A50126R00001_RFP_0001.SF30.pdf	PDF	Sep 11, 2026
14-75A50126R00001_RFP Att 14 Past Perfomance Questionnaire Template.docx	DOCX document	Aug 17, 2026
13-75A50126R00001_RFP Att 13 Risk Mitigation Plan Matrix Template.docx	DOCX document	Aug 17, 2026
01-75A50126R00001_RFP_Final.pdf	PDF	Aug 17, 2026
19_75A50126R0001_RFP Att 19 Surge Manufacturing and Supply Chain Readiness Assessment.pdf	PDF	Aug 17, 2026
18-75A50126R00001_RFP Att 18 BCP SCP Continuity Plans.pdf	PDF	Aug 17, 2026
16-75A50126R00001_RFP Att 16 Bill of Materials (BOM) Template.xlsx	XLSX spreadsheet	Aug 17, 2026
12-75A50126R00001_RFP Att 12 HHS Subcontracting Plan Template.docx	DOCX document	Aug 17, 2026
11-75A50126R00001_RFP Att 11 SF LLL Disclosure of Lobbying Activities Form Instructions.pdf	PDF	Aug 17, 2026
05-75A50126R00001_RFP Att 4 Agent Request Form.docx	DOCX document	Aug 17, 2026
03-75A0126R00001_RFP Att 2 ASPR Security Requirements.pdf	PDF	Aug 17, 2026
10-75A50126R00001_RFP Att 10 SF LLL Disclosure of Lobbying Activities Form.pdf	PDF	Aug 17, 2026
09-75A50126R00001_RFP Att 9 ACH Vendor Misc Payment Enrollment Form.docx	DOCX document	Aug 17, 2026
07-75A50126R00001_RFP Att 7 Breakdown of Proposed Costs.xlsx	XLSX spreadsheet	Aug 17, 2026
04-75A50126R00001_RFP Att 3 Vendor Production Facilities.xlsx	XLSX spreadsheet	Aug 17, 2026
15-75A50126R00001_RFP Att 15 Contractor Questions.xlsx	XLSX spreadsheet	Aug 17, 2026
17-75A50126R00001_RFP Att 17 Manufacturing Plan.pdf	PDF	Aug 17, 2026
08-75A50126R00001_ RFP Att 8 Summary of Related Activities.docx	DOCX document	Aug 17, 2026
02-75A50126R00001_RFP Att 1 Prod Handling Guidance Don Nat.pdf	PDF	Aug 17, 2026

Show all 24

On GovTribe

Work with this file

Download the original file
Contacts named in this file
Similar government files
Ask GovTribe AI about this file

Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

Intro

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Please complete as completely as possible and provide updates as necessary. Specific instructions regarding timing and refresh rate will be provided by the COR.

BARDA is using these forms to capture Vaccine, Therapeutic, and Hyperimmune globulin tracking, so some generalizations are unavoidable while these data should be specific enough to identify potential concerns and explain projection-to-actual discrepancies. Certain columns will not be appropriate for particular products (e.g. "Potency Assay 1" is not relevant for Hyperimmune globulin).

Data is intended to be submitted by various manufacturers under contract to BARDA, ASPR and/or DoD using the structure specified. It will then be combined centrally and reported on for BARDA leadership.

Submitted data and all data products will be considered FOUO, Proprietary and Company Confidential.

Tab Color Key

Green - Informational (Intro, Dictionary, Estimated Actual Report Example)

Blue - Occaisional/as-needed updates only (Master Data, SKU Lookup, Dose Projection)

Orange - Potential for daily updates during commercial-scale manufacturing (Bulk, Fill, Final Released, Inventory, Reallocation, Shipped)

Black - Reference/validation, do not edit (Reference Values)

Guidelines

The Dictionary tab gives details on the description and datatype for each field in this template - please reference this for specific guidance.

The first Estimated Actual tab simply gives an example of how this information is to be used; no action is requested.

The Master Data tab presents previously collected data regarding the organization, however needs to be supplemented with updated data. Please complete in full, as many of these items will be used in subsequent tabs as dropdown options.

The SKU Lookup tab, similar to the Master Data tab, will be used to help populate dropdown/lookup values in other tabs. We understand that a full list of SKUs may be unavailable initially and that this data would be filled in over time.

The Dose Projection Template tab provides a simplified table for reporting your manufacturing projections for the remainder of the year. This is used to complete the Projected rows in the Estmated Actual Report. Naturally we expect there will be some variance between this projection and actual manufacturing data.

Bulk, Fill, FinalReleased, Inventory, and Shipped tabs contain the bulk of the data ask. We ask that lot information be recorded as soon as known, and that these tabs become a ledger, including all prior data (except for Inventory, see below). This data ask has been customized to minimize the disruption to the company, and to maximze the amount of data that can be exported directly from ERP/MRP systems.

Inventory tab data should record the inventory at that reported time. That is, it should only report on those lots and volumes/quantities that are in inventory at the time of the "Data reported as of" datetime recorded in the first column.

The Reallocation tab is for recording damaged, expired, non-BARDA market, or other instances where portions of a lot may no longer be available for BARDA. This is to assist with accounting for all product manufacturered, and ensures that data in the BDS, Fill, and Final Released tabs can match quality paperwork - e.g. COA)

Shipped data should only include shipments that have occurred, and not project shipments that will/may occur in the future. Shipped doses plus inventory should equal the total doses manufactured.

The Reference Values tab shows dropdown options for many fields throughout the workbook and should not be edited. If you believe a new value needs to be added, please contact your COR or manufacturing POC who will be able to route your inquiry.

Any questions on this request should be addressed to the COR, who wil be able to appropriately route your inquiry.

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

&"Arial,Regular"&08&I&K000000The information in this document is proprietary to Leidos.

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Dictionary

	Spreadsheet Tab	Field	Notes	Responses	Definition	Required/Optional	Data Type
	Bulk Drug Substance	Data Reported as of			Date at which data was reported (i.e. when the data was confirmed accurate)	Required	Date
	Bulk Drug Substance	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Bulk Drug Substance	Starting Materials Lot #			Seed lot or other starting materials lot number used to promulgate bulk lot	Optional	Text
	Bulk Drug Substance	BDS_SKU		From SKU Lookup / SKU	Select the appropriate SKU for the Bulk Material being produced and reported in each row. The list of available SKUs is based on the SKUs entered in the SKU Lookup tab	Required	Enumerated list
	Bulk Drug Substance	BDS Lot #			Identifier for the batch of Bulk Material being produced	Required	Text
	Bulk Drug Substance	Volume On Hand (L)			Volume, in liters, of the bulk material produced in the batch	Required	Numeric
	Bulk Drug Substance	Expiration Date			Expiration Date of the bulk materials produced	Required	Date
	Bulk Drug Substance	Mfg Start Date			Date on which manufacturing of bulk drug substance material began	Required	Date
	Bulk Drug Substance	Mfg Date			Date of bulk drug substance manufacture (BDS leaves bulk suite)	Required	Date
	Bulk Drug Substance	Potency Assay 1			The quantity of active ingredient in a batch per ml. The unit of measure (one of: ug. Pfu, or VP) must be the same as set in the Dose Assumption parameter in the [Master Data] sheet.
Required for HHS calculation of projected doses.	Required	Numeric
	Bulk Drug Substance	Potency Assay 2 / Titer (Final)			Updated Potency Assay if a new value is available. This Potency Assay value will be used for HHS calculation of projected doses if it is provided	Required	Numeric
	Bulk Drug Substance	Internal Lot Release Date			Date of manufacturer-internal lot release	Required	Date
	Bulk Drug Substance	Remarks			Any comments/notes	Optional	Text
	Critical Materials	Product			Prepopulated based on Master Data / Product Name	Required	Auto populated
	Critical Materials	Dose Assumption			Prepopulated based on Master Data / Dose Assumption	Required	Auto populated
	Critical Materials	Supplier		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet.	Required	Enumerated list
	Critical Materials	Critical Material		Crimp, Seal, Stopper or vial	Select the appropriate critical material from the dropdown menu	Required	Enumerated list
	Critical Materials	Product Description			Type or description of the critical material	Required	Text
	Critical Materials	Part Number			Supplier's Part Number / SKU for the Crimp, Seal, Stopper, Vial or other critical material which is designated for COVID-19 response	Required	Text
	Critical Materials	Stockpile Quantity			Current number of Crimps, Seals, Stoppers or Vials in product manufacturer's inventory, set aside for USG COVID-19 response use, within the manufacturer's control as of the reporting date	Required	Numeric
	Critical Materials	Purchase Status		Contracted or Identified	Select Contracted if material is formally contracted for

Select Identified if material has been identified but not yet formally contracted for

For material not included in the stockpile quantity	Required	Enumerated list
	Critical Materials	Purchaser		Vendor or U.S. Government	Select Vendor if company is responsible for procurement from supplier
Select U.S. Government if USG is responsible for procurement from supplier and delivery to company	Required	Enumerated list
	Critical Materials	Week starting			Projected weekly delivery quantity of the critical material for large scale (non-clinical trial), US government, COVID-19 response use. (Exclude material included in stockpile quantity)	Required	Numeric
	Dose Projection	Product			Auto populated. Will match the Product from the Master Data sheet	Required	Auto populated
	Dose Projection	Dose Assumption			Auto populated. Will match the Dose Assumption from the Master Data sheet	Required	Auto populated
	Dose Projection	Manufacturing Facility (Location)		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Dose Projection	Material Type		Bulk, Finished	Each Dose Projection line item should be for either Bulk or Finished product.	Required	Enumerated list
	Dose Projection	NDC		From SKU Lookup / NDC	NDC for which Projection is being provided. Must match an NDC in the [SKU Lookup] sheet	Optional	Text
	Dose Projection	Week Of			Fill in projected numbers of projected Dose Equivalents of Bulk and/or Finished product Respectively for each week starting on the date at the top of each 'Week of' column. If the "Dose Projection Tracking Basis" parameter in the [Master Data] sheet is set to "Treatment Course", fill in the number of Treatment Courses trather than doses.	Required	Numeric
	Filled Drug Product	Data Reported as of			Indicate the date on which the reported data for each row is accurate	Required	Date
	Filled Drug Product	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Filled Drug Product	Fill SKU		From SKU Lookup / SKU	Select the appropriate SKU for the Filled Drug Product being produced and reported in each row. The list of available SKUs is based on the SKUs entered in the SKU Lookup tab	Required	Enumerated list
	Filled Drug Product	Date of Fill Start			Date filling of lot begins (may be same as fill completion)	Required	Date
	Filled Drug Product	Date of Fill Completion			Date filling of lot is complete	Required	Date
	Filled Drug Product	Fill Lot #			Identifier for the batch of Filled Drug Product being produced	Required	Text
	Filled Drug Product	Fill Qty			Actual quantity of units included in the Fill Lot, using the same unit defined for the referenced SKU. For instance if, the SKU references Vials (which is typical) then this is the number of vials in the Fill Lot.	Required	Numeric
	Filled Drug Product	Remarks				Optional	Text
	Final Released	Data Reported as of			Indicate the date on which the reported data for each row is accurate	Required	Date
	Final Released	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Final Released	Final / FDP SKU		From SKU Lookup / SKU	Select the appropriate SKU for the Final Released Drug Product being produced and reported in each row. The list of available SKUs is based on the SKUs entered in the SKU Lookup tab	Required	Enumerated list
	Final Released	Predecessor Fill Lot #		From Fill / Fill Lot #	The lot number of the fill lot that becomes this final lot	Required	Enumerated list
	Final Released	Final / FDP Lot #			Identifier for the batch of Final Released Drug Product being produced	Required	Text
	Final Released	Finish / FDP Qty			Actual quantity of units included in the Final Lot, using the same unit defined for the referenced SKU. For instance if, the SKU references Cartons (which is typical) then this is the number of cartons in the Final Lot.	Required	Numeric
	Final Released	FDA Lot Submission Date			Date samples of lot are sent to FDA for confirmatory testing	Required	Date
	Final Released	FDA Lot Approval Date			Date on which FDA Approval was granted for each listed Final Released Drug Product FDP Lot (batch) of the listed SKU.	Required	Date
	Final Released	Expiration Date			Lot expiry date noted on final package	Required	Date
	Final Released	Manufacture Date			Date of Final Drug Product Manufacture	Required	Date
	Final Released	Manufacturer Release Date			Date of Final Drug Product release by Manufacturer	Required	Date
	Final Released	Remarks				Optional	Text
	Reallocation	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Reallocation	Lot #		Must be a valid Lot Number, one of: Bulk, Fill, Final	Select the Lot (Bulk, Fill, or Final) affected by the Reallocation	Required	Text
	Reallocation	Reallocation Type		From reference list of Reallocation Types	Identify the end point of the reallocated quantity, such as clinical trials	Required	Enumerated list
	Reallocation	Date			Date of reallocation event	Required	Date
	Reallocation	Quantity			Quantity (in unit of SKU) of Final product reallocated	Required	Integer
	Reallocation	Remarks			Free text remarks	Optional	Text
	Reallocation	SKU		From SKU Lookup / SKU	SKU of the material Reallocated	Required	Enumerated list
	Inventory	Data Reported as of			Indicate the date on which the reported data for each row is accurate	Required	Date
	Inventory	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Inventory	Material SKU		From SKU Lookup / SKU	Select the appropriate SKU for the Final Released Drug Product captured in each row of the inventory.
The list of available SKUs is based on the SKUs entered in the SKU Lookup tab	Required	Enumerated list
	Inventory	Lot #			Lot number in inventory (can be bulk, fill, or final)	Required	Text
	Inventory	Storage Location Within Facility			Indicate where in the storage facility the material in this row is located	Required	Text
	Inventory	Inventory on Hand			Quantity of material on hand for this row's SKU and Lot	Required	Numeric
	Inventory	Units of Inventory on Hand	Dropped, do not fill in		[Instead of using a unit value from here, the Units of Inventory in hand are defined per the referened SKU. For instance, if the SKU is based on cartons, then the quantity of inventory should be entered in cartons.]	Required	Text
	Inventory	Remarks				Optional	Text
	Manufacturing Capacity	Product			Prepopulated based on Master Data / Product Name	Required	Auto populated
	Manufacturing Capacity	Dose Assumption			Prepopulated based on Master Data / Dose Assumption	Required	Auto populated
	Manufacturing Capacity	Manufacturing Facility (Location)		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Manufacturing Capacity	Material Type		Bulk or Finished		Required	Enumerated list
	Manufacturing Capacity	Status		Reserved or Unreserved / Available	Contractual or other availability of location performing the work	Required	Enumerated list
	Manufacturing Capacity	Batch Scale			Size of each batch. For instance, a 200 liter batch has a batch size of 200.	Required	Numeric
	Manufacturing Capacity	Unit			Unit of measure for each batch. For instance, a 200 liter batch has a Unit of L. If the vendor needs to enter a unit beyond the set of available choices, please provide information about the proposed unit, and BARDA will provide instructions on how to update the template	Required	Text
	Manufacturing Capacity	Week Starting			Projected Manufacturing Capacity represented as the number of batches of the product/material each week starting on the date at the top of each 'Week Starting' column. May be expressed as a decimal	Required	Numeric
	Master Data	Contract #			Contract number for the product manufacturing process	Required	Text
	Master Data	Vendor Company			Name of the parent company/prime contractor associated with the contract. The parent company may have multiple company locations tracked in this spreadsheet.	Required	Text
	Master Data	Task Order # (if applicable)			Task Order for the Contract Number	Optional	Text
	Master Data	Mfr_Template_Id (do not edit)			Pre-Populated to support the data aggregation process. Do not change this number	Required	Numeric
	Master Data	Product Name			Product Name	Required	Text
	Master Data	Product Type		Therapeutic - Convalescent Plasma, Therapeutic - Hyperimmune Globulin, Therapeutic - Monoclonal Antibody, Therapeutic - Other, Therapeutic - Small Molecule, Vaccine - Cell, Vaccine - Conjugate, Vaccine - DNA, Vaccine - Inactivated, Vaccine - Live Attenuated, Vaccine - mRNA, Vaccine – Other, Vaccine - Recombinant, Vaccine - SubUnit, Vaccine - Toxoid		Required	Enumerated list
	Master Data	NDC Number (once available)			FDA NDC number for the product being produced	Optional	Text
	Master Data	Dose Assumption / Central Estimate			The quantity of active ingredient, for instance as measured in ug, VP, or pfu, included in one dose of the vaccine. The Central Estimate is required, and should be the vendor's best estimate of the expected dose based on currently available information.	Required	Numeric
	Master Data	Dose Assumption / Lower Estimate			The lowest dose being evaluated in current vaccine trials, or that is otherwise in a realistic range of what could be the final dose after trials are completed.	Optional	Numeric
	Master Data	Dose Assumption / Upper Estimate			The highest dose being evaluated in current vaccine trials, or that is otherwise in a realistic range of what could be the final dose after trials are completed.	Optional	Numeric
	Master Data	Dose Assumption / Unit			Unit of measure for Dose Assumption being one of: ug, pfu, or VP. If the vendor needs to enter the Dose Assumption in a different unit, please provide information about the unit of measure, and BARDA will provide instruction for updating the template.	Required	Text
	Master Data	Dose Assumption / Data Note			Any notes specific to dose assumption. For clarity, prefer an explicit textual re-representation of dose and regimen in treatment course (e.g.: Central estimate assumes a 15ug dose administered twice spaced 21 days apart for a total of 30ug antigen delivered in the treatment course)	Optional	Text
	Master Data	Regimen / Central Estimate			The number of doses expected to comprise a Course of Treatment of one patient.	Required	Numeric
	Master Data	Regimen / Lower Estimate			The lowest number of doses required to make up a single treatment course	Optional	Numeric
	Master Data	Regimen / Upper Estimate			The highest number of doses required to make up a single treatment course	Optional	Numeric
	Master Data	Regimen / Unit			This unit is always "dose", do not edit.	Required	Text
	Master Data	Regimen / Data Note			See dose assumption data note.	Optional	Text
	Master Data	# Doses in MDV / Central Estimate			Number of full doses in the final vial as will be listed on the package insert	Required	Numeric
	Master Data	# Doses in MDV / Lower Estimate			Not Required	Optional	Numeric
	Master Data	# Doses in MDV / Upper Estimate			Not Required	Optional	Numeric
	Master Data	# Doses in MDV / Unit			This unit is always "dose", do not edit.	Required	Text
	Master Data	# Doses in MDV / Data Note			Any explanatory notes for # of doses in MDV	Optional	Text
	Master Data	DS Release Time Fill To Finish / Central Estimate			Time, in days, from bulk manufacture to internal lot release of material making it available for formulation/fill/finish activities. Do not account for formulation/filling at-risk; these will be accounted for separately	Required	Numeric
	Master Data	DS Release Time Fill To Finish / Lower Estimate			Not Required	Optional	Numeric
	Master Data	DS Release Time Fill To Finish / Upper Estimate			Not Required	Optional	Numeric
	Master Data	DS Release Time Fill To Finish / Unit			This unit is always "day", do not edit.	Required	Numeric
	Master Data	DS Release Time Fill To Finish / Data Note			Any explanatory notes for timing of bulk to fill	Optional	Text
	Master Data	DP release for final distribution / Central Estimate			Time, in days, from fill completion to final release (not accounting for potential non-lot-specific delays awaiting FDA approval of product generally)	Required	Numeric
	Master Data	DP release for final distribution / Lower Estimate			Not Required	Optional	Numeric
	Master Data	DP release for final distribution / Upper Estimate			Not Required	Optional	Numeric
	Master Data	DP release for final distribution / Unit			This unit is always "day", do not edit.	Required	Text
	Master Data	DP release for final distribution / Data Note			Any explanatory notes for timing of fill completion to final release (especially if this timing could differ by location)	Optional	Text
	Master Data	Bulk Loss Factor for Projections / Central Estimate			Enter the Bulk Loss Factor used for Dose Projections. This should be entered as a decimal ratio. For instance a 30% loss factor is entered as 0.3.	Required	Numeric
	Master Data	Bulk Loss Factor for Projections / Unit			This unit is always "ratio", do not edit.	Required	Text
	Master Data	Bulk Loss Factor for Projections / Data Note			Any explanatory notes for Bulk Loss Factor for Projections	Optional	Text
	Master Data	Bulk Potency Assumption for Projections / Central Estimate			Potency Assumption used in bulk dose projections, entered in the same units as Dose Assumption per milliliter of Bulk Drug Substance	Required	Numeric
	Master Data	Bulk Potency Assumption for Projections / Unit			This unit is always the same unit as Dose Assumption, do not edit.	Required	Text
	Master Data	Bulk Potency Assumption for Projections / Data Note			Any explanatory notes for Potency Assumption for Projections	Optional	Text
	Master Data	Organization Name			Name of the company associated with the Contract location	Required	Text
	Master Data	Contractor Entity Type		Prime, Sub-contractor, Supplier	Indicate if the organization is the Prime contractor or a subcontractor on the contract	Required	Enumerated list
	Master Data	Street 1			Address information associated the organization /location listed in the Master Data tab	Required	Text
	Master Data	Street 2			Address information associated the organization /location listed in the Master Data tab	Optional	Text
	Master Data	City			Address information associated the organization /location listed in the Master Data tab	Required	Text
	Master Data	State or Province			Address information associated the organization /location listed in the Master Data tab	Required	Text
	Master Data	Zip or Postal Code			Address information associated the organization /location listed in the Master Data tab	Required	Text
	Master Data	Country			Address information associated the organization /location listed in the Master Data tab	Required	Text
	Master Data	DUNS #			Nine digit code used to identify a company and location. The DUNS code for the company and location should be registered with SAM	Required	Text
	Master Data	CAGE Code			Five character alpha numeric id	Optional	Text
	Master Data	IsGlobalHQ?		Yes, No	Yes, if the location is the company's Global HQ	Optional	Yes/No
	Master Data	IsUSAHQ?		Yes, No	Yes, if the location is the company's US HQ	Optional	Yes/No
	Master Data	IsPrimaryAwardedAddress?		Yes, No	Is the location the primary location for the contract	Required	Yes/No
	Master Data	Location POC Last			Last name of manufacturing POC at location	Required	Text
	Master Data	Location POC First			First name of manufacturing POC at location	Required	Text
	Master Data	Location POC Email			Email address of manufacturing POC at location	Required	Text
	Master Data	Location POC Phone			Phone Number of manufacturing POC at location	Required	Text
	Master Data	Laboratory Testing		Yes, No	Yes, if the location can be used for Laboratory Testing for the product associated with the contract	Required	Yes/No
	Master Data	Raw Materials Production		Yes, No	Yes, if the location can be used for Raw Materials Production for the product associated with the contract	Required	Yes/No
	Master Data	Precursor Materials Production		Yes, No	Yes, if the location can be used for Precursor Materials Production for the product associated with the contract	Required	Yes/No
	Master Data	Drug Substance (Bulk) Manufacturing		Yes, No	Yes, if the location can be used for Drug Substance (Bulk) Manufacturing for the product associated with the contract	Required	Yes/No
	Master Data	Drug Product (Formulation/Filling) Activities		Yes, No	Yes, if the location can be used for Drug Product (Formulation/Filling) Activities for the product associated with the contract	Required	Yes/No
	Master Data	Finishing Activities		Yes, No	Yes, if the location can be used for Finishing Activities for the product associated with the contract	Required	Yes/No
	Master Data	Administrative		Yes, No	Yes, if the location can be used for Administrative activities for the product associated with the contract	Required	Yes/No
	Master Data	Non-Clinical Studies		Yes, No	Yes, if the location can be used for Non-Clinical Studies for the product associated with the contract	Required	Yes/No
	Master Data	Clinical Studies		Yes, No	Yes, if the location can be used for Clinical Studies for the product associated with the contract	Required	Yes/No
	Master Data	Device Manufacturing		Yes, No	Yes, if the location can be used for Device Manufacturing for the product associated with the contract	Required	Yes/No
	Master Data	Storage/Stability/Shipping		Yes, No	Yes, if the location can be used for Storage/Stability/Shipping activities for the product associated with the contract	Required	Yes/No
	Shipped (out of inventory)	Data Reported as of			Indicate the date on which the reported data for each row is accurate	Required	Date
	Shipped (out of inventory)	Location Shipped From		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Shipped (out of inventory)	BOL Shipment ID			Bill of Lading shipment identifier	Required	Text
	Shipped (out of inventory)	SKU		From SKU Lookup / SKU	Select from the SKUs that have been entered on the SKU Lookup tab	Required	Enumerated list
	Shipped (out of inventory)	Consignee			Entity financially responsible for receipt of shipment noted on bill of lading. If USG, specify which entity (e.g. HHS/CDC, HHS/BARDA, etc.)	Required	Text
	Shipped (out of inventory)	Ship To			Destination Address	Required	Text
	Shipped (out of inventory)	Carrier Name			Shipping Company (e.g. USPS, UPS, FedEx)	Required	Text
	Shipped (out of inventory)	Carrier Alpha Code			Four-digit standard carrier alpha code (SCAC) for carrier (e.g. USPC for the United States Postal Service)	Required	Text
	Shipped (out of inventory)	Trailer Number			Identifier number of trailer carrying goods	Required	Text
	Shipped (out of inventory)	Seal Number			Seal number applied when leaving dock	Required	Text
	Shipped (out of inventory)	Shipment Date			Date on which the shipment departs the originating location for the destination location	Required	Date
	Shipped (out of inventory)	Packing List ID			Delivery / Packing List ID	Required	Text
	Shipped (out of inventory)	Customer PO #			Customer Purchase Order Number	Required	Text
	Shipped (out of inventory)	Quantity			Quantity of product (in units of sale) being shipped	Required	Text
	Shipped (out of inventory)	Lot Number			Lot number of product being shipped (should match a final lot number)	Required	Text
	Shipped (out of inventory)	Expiration Date			Lot expiry date noted on final package (should match the value for the lot being shipped)	Required	Date
	Shipped (out of inventory)	Remarks				Optional	Text
	SKU Lookup	Manufacturer			Company Name. Should match "Organization" from the Master Data tab	Required	Text
	SKU Lookup	SKU			SKUs associated with products for the contract. A full list of SKUs may be unavailable initially and that this data would be filled in over time.
This should not include Critical Materials.	Required	Text
	SKU Lookup	SKU Description			Description of each SKU	Required	Text
	SKU Lookup	Product Component Type		Bulk, Bulk Adjuvant, Filled Adjuvant, Final Adjuvant, Final Released Product	Select the appropriate product component type for each listed SKU	Required	Enumerated list
	SKU Lookup	Product Classification		Clinical, Commercial	Indicate if each SKU is Clinical or Commercial	Required	Enumerated list
	SKU Lookup	High Variance	Bulk Only		Dose conversion variance for use in bulk to filled dose formula. Account for variability in assay. Expressed as a percentage, e.g. 125%	Required	Numeric
	SKU Lookup	Low Variance	Bulk Only		Dose conversion variance for use in bulk to filled dose formula. Account for variability in assay. Expressed as a percentage, e.g. 75%	Required	Numeric
	SKU Lookup	Loss Factor	Bulk and Fill Only		Required for HHS calculation of projected doses. Percentage of the total volume or units that can be expected to be lost, wasted or unusable at the completion of the production process.
((VolumePotency Assay)/Dose)(1-Loss Factor)=Projected Final Doses	Required	Numeric
	SKU Lookup	Unit of SKU			Unit of measure used to quantify any lots referencing this SKU	Required	Text
	SKU Lookup	Presentation	Fill and Final Only		Final Container, e.g. Multi-Dose Vial (MDV), Pre-Filled Syringe (PFS), Nasal Sprayer, Jet Injector	Required	Text
	SKU Lookup	Doses Per Unit	Fill and Final Only		Number of doses included in each unit of sale. e.g. 10 if the Unit of sale is Ten-pack single doses pre-filled syringe	Required	Numeric
	SKU Lookup	Dose/Concentration Target	Fill and Final Only		Expected (and eventually FDA-confirmed) dose target as noted on package insert. Required for HHS calculation of projected doses.	Required	Numeric
	SKU Lookup	Dose Target Units	Fill and Final Only		Units of dose target (e.g. ug, VP, or pfu). Required for HHS calculation of projected doses.	Required	Text
	SKU Lookup	FDA Approval	Final Product Only	Approved, Emergency Use Authorization, Pending Approval, Pending Emergency Use Authorization	Current FDA approval for the product. Select from list.	Required	Enumerated list
	SKU Lookup	Age Indication	Final Product Only		Age indication of product. If pre-approval, list age indication sought and update upon FDA approval.	Required	Text
	SKU Lookup	Subtype			Subtype of disease that is targeted		Enumerated list
	SKU Lookup	Strain			Strain that is targeted		Text
	SKU Lookup	Candidate Vaccine Virus			Specific virus used to create the seed or bulk		Text
	SKU Lookup	Regimen	Final Product Only		Number of doses in a treatment course		Integer
	SKU Lookup	BDS Release Days To Finish	Bulk Only		Number of days from Bulk Lot release to Manufacture of Final		Integer
	SKU Lookup	FDP Days to Final Release	Final Product Only		Number of days from Manufacture of Final to release		Integer
	SKU Lookup	Separate Adjuvant Required	Final Product Only		Indicate if a separate adjuvant is required for the product		Yes/No
	Seed	Data Reported as of			Indicate the date on which the reported data for each row is accurate	Required	Date
	Seed	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Seed	Seed_SKU		From SKU Lookup / SKU	Select the appropriate SKU for the Seed Material being produced and reported in each row. The list of available SKUs is based on the SKUs entered in the SKU Lookup tab	Required	Enumerated list
	Seed	Seed Lot #			Identifier for the batch of Seed Material being produced	Required	Text
	Seed	Candidate Vaccine Virus			Long form identifier of Candidate Vaccine Virus used to generate Seed Lot	Required	Text
	Seed	Volume Manufactured (L)			NEEDS REVIEW: Volume of seed material generated (need to change to number of ampules or some other quantity metric)	Required	Numeric
	Seed	CVV Source			Location, including lab, the CVV was received from (or "Self" if generated internally). Should match a lab listed in the WHO Influenza Virus Traceability Mechanism.	Required	Text
	Seed	Date CVV Received / Generated			Date the Candidate Vaccine Virus was received by company or was generated	Required	Date
	Seed	Date Seed Produced			Date Working Seed Produced	Required	Date
	Seed	Date Seed Sent to FDA			Date Working Seed Sent to FDA	Required	Date
	Seed	Date FDA Certified Seed			Date of FDA Certification of Working Seed	Required	Date
	Seed	Date CDC Concurs on Seed			Date of CDC Concurrence of Working Seed	Required	Date
	Seed	Remarks				Optional	Text
	Stability	Data Reported as of			Indicate the date on which the reported data for each row is accurate	Required	Date
	Stability	Location		From Master Data / Location Composite Name	Select the appropriate value from the list. The options are populated based on the Location Composite Name from the Master Data sheet	Required	Enumerated list
	Stability	Material SKU		From SKU Lookup / SKU	Select the appropriate SKU for the Bulk Drug Substance, Filled Drug Product, or Final Released Drug Product captured in each row of the Stability table.
The list of available SKUs is based on the SKUs entered in the SKU Lookup tab	Required	Enumerated list
	Stability	Lot #			Lot number in stability testing (can be bulk, fill, or final)	Required	Text
	Stability	Lot Type		Bulk, Fill, Final	Type of Lot	Required	Enumerated list
	Stability	Stability Date			Date stability value is taken	Required	Date
	Stability	Stability Value			Measured stability value for this lot (in mcg/ml)	Required	Numeric
	Stability	Stability Study		Ref Stability Study / Stability Study Number	Identifying number for the stability study; must be consistent for all lots in the same study, and should be unique compared to all other studies.	Required	Enumerated list
	Stability	Remarks			Free text remarks	Optional	Text
	Stability Study	Stability Study Number			Unique number of the stability study	Required	Text
	Stability Study	Stability Study Description			Description of stability study (longer form identifier)	Required	Text
	Stability Study	Remarks			Free text remarks	Optional	Text

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Master Data

Dose Tracking Template

Enter just one Contract # / Task # and just one Product, plus a collection of Locations supporting manufacture of that product

US Department of Health and Human Services, ASPR/BARDA

Initial locations have been generated from previously submitted data, where available. First line is for sample values.

Template Version 3.2 August 20, 2025

Mfr_Template_Id (do not edit)

All information submitted is Company Confidential

Contract #

HHSO1TESTTESTTESTC

Parameter

Central Estimate

Lower Estimate

Upper Estimate

Unit

Data Note

Vendor Company

Test Company

Bulk Loss Factor for Projections

ratio

Task Order # (if applicable)

Dose Projection Tracking Basis

Dose

Product Name

Test

Bulk Potency Assumption for Projections

ug/ml

Product Type

Vaccine - Cell

Location #

Location Composite Name

Organization Name

Contractor Entity Type

Street 1

Street 2

City

State or Province

Zip or Postal Code

Country

DUNS #

CAGE Code

IsGlobalHQ?

IsUSAHQ?

IsPrimaryAwardedAddress?

Location POC Last

Location POC First

Location POC Email

Location POC Phone

Laboratory Testing

Raw Materials Production

Precursor Materials Production

Drug Substance (Bulk) Manufacturing

Drug Product (Formulation/Filling) Activities

Finishing Activities

Administrative

Non-Clinical Studies

Clinical Studies

Device Manufacturing

Storage/Stability/Shipping

TEST

TEST Inc.

Prime

1234 Main Street

Cambridge

02139

USA

99999999

TEST1

Yes

Test

test@sdw.com

Yes

To add a line in addition to the lines provided, INSERT above the last line

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

&"Arial,Regular"&08&I&K000000The information in this document is proprietary to Leidos.

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

mailto:test@sdw.com SKU Lookup

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Bulk Only

Fill and Final Only

Final Product Only

Bulk Only

Final Product Only

Manufacturer

SKU

SKU Description

Product Component Type

Product Classification

NDC

High Variance

Low Variance

Loss Factor

Unit of SKU

Presentation

Doses Per Unit

Dose Target

Dose Target Units

FDA Approval

Age Indication

Subtype

Strain

Candidate Vaccine Virus

Regimen

BDS Release Days To Finish

FDP Days to Final Release

Separate Adjuvant Required

Test

FinalSKU01

Test Final

Final/Released Product

Commercial

Test-Final-TestC-99464543

Carton

Carton of MDVs

100

7.5

6mo+

H5N1

2020TestStrain01

Test

FillSKU01

Test Fill

Fill

Commercial

Test-Fill-TestC-88553344

Vial

MDV

7.5

H5N1

2020TestStrain01

Test

SeedSKU01

Test Seed

Seed

Clinical

Test-Seed-TestC-88994466

H5N1

2020TestStrain01

TEST/Virus

Test

FillSKU-ADJ

Test Filled Adjuvant

Filled Adjuvant

Clinical

Test-Adjuvant-TestC-88779955

Vial

7.5

Test

BULKSKU-ADJ

Test Bulk Adjuvant

Bulk Adjuvant

Clinical

Test-Adjuvant-TestC-22335588

10%

0.8

Test

BULKSKU01

Test Bulk

Bulk

Clinical

Test-Bulk-TestC-22335589

125%

75%

40%

7.5

H5N1

2020TestStrain01

To add a line in addition to the lines provided, INSERT above the last line

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Seed

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Data Reported as of

Location

Seed_SKU

Seed Lot #

Quantity Produced

CVV Source

Date Seed Produced

Seed Certification Date

Remarks

Lot Owner

Contract Number

Requisition

Expiration Date

4/30/24

Test

SeedSKU01

138645

105

WHO Collaborating Centre - CDC

8/27/12

1/31/13

Test

HHS

N/A

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Bulk Drug Substance

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Data Reported as of

Location

Starting Materials Lot #

BDS_SKU

BDS Lot #

Quantity Produced

Expiration Date

Mfg Start Date

Mfg Date

Potency Assay 1

Potency Assay 2 / Titer (Final)

Internal Lot Release Date

Remarks

Projected Dose Total

Lot Owner

Contract Number

Requisition

Stability Lot Number(s)

6/14/26

Test

138645

BULKSKU01

256279-1

12/3/28

6/3/23

101

6/20/23

Test1c

404,000

HHS

HHSO1TESTTESTTESTC

ASP123456

256279-1

6/14/26

Test

138645

BULKSKU01

256279-2

12/3/28

6/4/23

120

6/21/23

Test1c

384,000

HHS

HHSO1TESTTESTTESTC

ASP123456

256279-2

6/14/26

Test

138645

BULKSKU01

256279-3

12/3/28

6/5/23

108

6/22/23

Test1c

388,800

HHS

HHSO1TESTTESTTESTC

ASP123456

256279-1, 256279-2

6/14/26

Test

BULKSKU-ADJ

1234-01

6/20/34

6/20/23

7/10/23

Test1c-Adjuvant

75,502

HHS

HHSO1TESTTESTTESTC

ASP999999

N/A – Adjuvant

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Filled Drug Product

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Data Reported as of

Location

Fill SKU

Date of Fill Start

Date of Fill Completion

Fill Lot #

Fill Qty

Remarks

Projected Fill Start Date

Projected Fill Quantity

Lot Owner

Contract Number

Requisition

Expiration Date

6/14/24

Test

FillSKU01

6/8/24

189032

36,000

Test

HHS

HHSO1TESTTESTTESTC

Test111cc

6/8/27

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Final Released

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Data Reported as of

Location

Final / FDP SKU

Predecessor Fill Lot #

Final / FDP Lot #

Finish / FDP Qty

FDA Lot Submission Date

FDA Lot Approval Date

Expiration Date

Manufacture Date

Manufacturer Release Date

Remarks

Target Release Date

Target Finish FDP Qty

Lot Owner

Contract Number

Requisition

3/6/24

Test

FinalSKU01

189032

190039

2,400

7/23/24

4/1/28

4/1/25

4/20/25

Test1c

HHS

HHSO1TESTTESTTESTC

Test111cc

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Stability

Dose Tracking Template
US Department of Health and Human Services, ASPR/BARDA
Template Version 3.2 August 20, 2025
All information submitted is Company Confidential
Data Reported as of	Location	Lot #	Lot Type	Stability Date	Stability Value	Stability Study	Remarks
6/20/24	Test	256279-1	Bulk	6/20/24	99	2020TestStrain01 SRID	0M
9/20/24	Test	256279-1	Bulk	9/20/24	94	2020TestStrain01 SRID	3M
12/20/24	Test	256279-1	Bulk	12/20/24	97	2020TestStrain01 SRID	6M
6/20/25	Test	256279-1	Bulk	6/20/25	89	2020TestStrain01 SRID	12M
9/20/24	Test	256279-2	Bulk	6/20/24	116	2020TestStrain01 SRID	0M
9/20/24	Test	256279-2	Bulk	9/20/24	108	2020TestStrain01 SRID	3M
12/20/24	Test	256279-2	Bulk	12/20/24	112	2020TestStrain01 SRID	6M
6/20/25	Test	256279-2	Bulk	6/20/25	102	2020TestStrain01 SRID	12M
11/30/22	Test	189032	Fill	12/8/24	20	2020TestStrain01 Fill	6M

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Stability Study

Dose Tracking Template
US Department of Health and Human Services, ASPR/BARDA
Template Version 3.2 August 20, 2025
All information submitted is Company Confidential
Stability Study Number	Stability Study Description	Remarks	Use for Stability Calcs
1	2020TestStrain01 SRID	Bulk	Yes
2	2020TestStrain01 HPLC	Bulk	No
3	2020TestStrain01 Fill	Fill	Yes

Reallocation

Dose Tracking Template
US Department of Health and Human Services, ASPR/BARDA
Template Version 3.2 August 20, 2025
All information submitted is Company Confidential
Location	Lot #	Reallocation Type	Date	Quantity	Remarks	SKU
TEST	190039	Clinical Trials	10/13/24	5		FinalSKU01
TEST	256279-1	Stability Study	10/13/24	2	Support 5yr extension to the stability study	BULKSKU01
TEST	256279-2	Stability Study	10/14/24	3	Support 5yr extension to the stability study	BULKSKU01

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Inventory

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Data Reported as of	Location	SKU	Lot #	Storage Location Within Facility	Inventory on Hand	Leave blank, Was: Units of Inventory on Hand	Remarks
5/15/26	TEST	FillSKU01	189032		12,000
5/15/26	TEST	FinalSKU01	190039		2,395
5/15/26	TEST	BULKSKU01	256279-1		48
5/15/26	TEST	BULKSKU01	256279-2		37
5/15/26	TEST	BULKSKU01	256279-3		- 0		Used to Fill Lot 189032
5/15/26	TEST	BULKSKU-ADJ	1234-01		60

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Shipped (out of inventory)

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

Data Reported as of

Location Shipped From

BOL Shipment ID

SKU

Consignee

Ship To

Carrier Name

Carrier Alpha Code

Carrier Tracking Number

Trailer Number

Seal Number

Shipment Date

Packing List ID

Customer PO #

Customer PO Line #

Quantity

Lot Number

Expiration Date

Remarks

Special Case

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

Reference Values

Dose Tracking Template

US Department of Health and Human Services, ASPR/BARDA

Template Version 3.2 August 20, 2025

All information submitted is Company Confidential

DO NOT EDIT ANY VALUES IN THIS SHEET

Product Type

Bulk or Finished

Dose Unit

Product Component Type

Product Classification

FDA Approval

Status

Boolean

Contractor_Type

Critical Material

Purchaser

Purchase Status

Dose Unit

SKU Unit

Yes/No

Shipment Special Case

Dose Tracking Basis

Reallocation Type

Reallocation Lot Type

Therapautic - Convalescent Plasma

Bulk

Projected Bulk (final dose equivalents)

Seed

Clinical

Approved

Reserved

Yes

Prime

Crimp

U.S. Government

Contracted

pfu

Carton

Replace Damaged Product

Dose

Approved For Destruction

Bulk

Therapautic - Hyperimmune Globulin

Finished

Projected Finished Container (dose equivalent)

Bulk

Commercial

Emergency Use Authorization

Unreserved/Available

Sub-contractor

Seal

Vendor

Identified

dose

Yes

Treatment Course

Clinical Trials

Fill

Therapautic - Monoclonal Antibody

Adjuvant

Bulk Adjuvant

Pending Approval

Supplier

Stopper

Clinical Trials USG Paid

Final

Therapeutic - Other

Fill

Pending Emergency Use Authorization

Vial

Damaged

Seed

Therapautic - Small Molecule

Filled Adjuvant

Expired

Vaccine - Cell

Final Adjuvant

Non-BARDA Market

Vaccine - Conjugate

Final/Released Product

Quarantine

Vaccine - DNA

Syringe

Stability Study

Vaccine - Inactivated

Vial

Vaccine - Live Attenuated

Vaccine - mRNA

Vaccine - Other

Vaccine - Recombinant

Vaccine - SubUnit

Vaccine - Toxoid

&"Arial,Regular"&09&I&K000000Leidos Proprietary

&"Calibri,Regular"&10

It may not be used, reproduced, disclosed, or exported without the written approval of Leidos.

File details come from the government source that posted it. Updated Aug 30, 2026.